TRAP220 Polyclonal Antibody, 50ul[BT-AP09180] Immunoassays autosomal dominant progressive external ophthalmoplegia-5

autosomal dominant progressive external ophthalmoplegia-5

tissue specificity:Expressed in kidney

and are involved in stem cell development

Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4

Pyruvate dehydrogenase phosphatases catalyze the dephosphorylation and activation of the E1 component to reverse the effects of pyruvate dehydrogenase kinases

TRAP220 Polyclonal Antibody, 50ul[BT-AP09180] Immunoassays autosomal dominant progressive external ophthalmoplegia-5The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by MED1 (mediator complex subunit 1) is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1.